Scarica l'app Stockscreener
0.5619
2.65%
0.0145
Dopo l'orario di chiusura:
.58
0.0181
+3.22%
Precedente Chiudi:
$0.5474
Aprire:
$0.5449
Volume 24 ore:
1.00M
Relative Volume:
1.78
Capitalizzazione di mercato:
$9.14M
Reddito:
-
Utile/perdita netta:
$-12.47M
Rapporto P/E:
-0.6167
EPS:
-0.9111
Flusso di cassa netto:
$-10.10M
1 W Prestazione:
-33.02%
1M Prestazione:
-44.91%
6M Prestazione:
-63.98%
1 anno Prestazione:
-42.57%
Intervallo 1D:
$0.5324
$0.5866
Intervallo di 1 settimana:
$0.50
$0.895
Portata 52W:
$0.50
$2.115
Hoth Therapeutics Inc Stock (HOTH) Company Profile
Nome
Hoth Therapeutics Inc
Settore
Industria
Telefono
(646)756-2997
Indirizzo
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
Compare HOTH vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOTH
Hoth Therapeutics Inc
|
0.5619 | 9.14M | 0 | -12.47M | -10.10M | -0.9111 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-10-15 | Iniziato | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc Borsa (HOTH) Ultime notizie
Guidance Update: Whats the fair value of Hoth Therapeutics Inc stock2026 Earnings Surprises & Stock Timing and Entry Methods - baoquankhu1.vn
Hoth Therapeutics closes $2 million registered direct offering By Investing.com - Investing.com Canada
Hoth Therapeutics announces closing of $2 million registered direct offering - marketscreener.com
Hoth Therapeutics Completes Registered Direct Offering Financing - TipRanks
Hoth Therapeutics Raises $2M in Registered Direct Offering - National Today
Hoth Therapeutics closes $2 million registered direct offering - Investing.com
Hoth Therapeutics Raises $2 Million in Registered Direct Offering; Issues Five-Year Warrants - TradingView
Hoth Therapeutics (NASDAQ: HOTH) closes $2M registered direct stock deal - Stock Titan
Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering - PR Newswire
Hoth Therapeutics (NASDAQ: HOTH) raises ~$2.0M; concurrent warrants issued - Stock Titan
Hoth Therapeutics’ HT-001 meets primary endpoint in interim analysis By Investing.com - Investing.com South Africa
Hoth Therapeutics raises $2M in registered direct offering By Investing.com - Investing.com Australia
Hoth Therapeutics raises $2M in registered direct offering - Investing.com
Hoth Therapeutics Announces $2.0 Million Registered Direct Offering - PR Newswire
Hoth Therapeutics’ HT-001 meets primary endpoint in interim analysis - Investing.com
Cancer rash drug cut pain for 65% of patients without disrupting therapy - Stock Titan
Hoth Therapeutics receives China patent for mast cell therapy By Investing.com - Investing.com Australia
Energy Moves: Is Hoth Therapeutics Inc stock trending bullish2026 Dividend Review & AI Enhanced Trading Signals - baoquankhu1.vn
Hoth Therapeutics receives China patent for mast cell therapy - Investing.com
Hoth Therapeutics announces issuance of Chinese patent for cancer cell-targeting technology - marketscreener.com
China patent backs Hoth technology designed to kill mast cells - Stock Titan
Moving Averages: Is Hoth Therapeutics Inc a good ESG investment2026 Trade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn
Hoth Therapeutics 2025 Annual Report: Clinical-Stage Biopharmaceutical Pipeline, FDA Regulatory Pathways, and Risk Factors Overview - Minichart
Hoth Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Hoth Therapeutics 10-K: $0 Revenue, $(0.90) EPS, $(12.47)M Net Loss - TradingView
Hoth Therapeutics (NASDAQ: HOTH) warns on cash needs and going‑concern risk - Stock Titan
Hoth Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Aug Sentiment: Will Hoth Therapeutics Inc stock recover after earningsOptions Play & Weekly Setup with ROI Potential - baoquankhu1.vn
Hoth Therapeutics launches AI platform for drug discovery By Investing.com - Investing.com Canada
Hoth Therapeutics Launches OpenClaw AI for Accelerating Drug Discovery - Contract Pharma
HOTH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Hoth Therapeutics Deploys OpenClawtm AI Platform to Accelerate Drug Discovery - Lelezard
Hoth Therapeutics launches AI platform for drug discovery - Investing.com
Hoth Therapeutics Deploys OpenClaw™ AI Platform to Accelerate Drug Discovery - PR Newswire
EXCLUSIVE: Hoth Therapeutics Targets Faster Drug Discovery With New AI Platform - Benzinga
Hoth Therapeutics (NASDAQ:HOTH) Receives Buy Rating from D. Boral Capital - Defense World
HOTH: Analyst Jason Kolbert Maintains Buy Rating with $5 Target Price | HOTH Stock News - gurufocus.com
Hoth Therapeutics Inc Deploys OpenClaw AI Platform to Accelerate Drug Discovery - marketscreener.com
Hoth reports positive pharmacokinetic data for topical HT-001 By Investing.com - Investing.com Australia
Hoth reports positive pharmacokinetic data for topical HT-001 - Investing.com
Hoth Therapeutics Reports Positive Ht-001 Pk, Safety, And Clinical Activity Data In Cancer Patients With Egfr Therapy - TradingView
Hoth Therapeutics Reports Positive HT-001 PK, Safety, and Clinical Activity Data in Cancer Patients with EGFR Therapy-Associated Skin Toxicities Showing ~77% Increase in Drug Exposure and Minimal Systemic Absorption - PR Newswire
Hoth Therapeutics stock faces biotech volatility amid pipeline updates and market pressures - AD HOC NEWS
Hoth Therapeutics shares climb after expanding AI partnership with NVIDIA - MSN
Hoth Therapeutics gains after winning China patent for HT-KIT cancer program - MSN
Fed Meeting: Will Hoth Therapeutics Inc announce a stock splitMarket Movers & Verified Momentum Stock Alerts - baoquankhu1.vn
Aug EndMonth: How much upside does Hoth Therapeutics Inc have2026 Setups & Advanced Technical Signal Analysis - baoquankhu1.vn
Hoth Therapeutics reports preclinical data on obesity treatment - Investing.com Nigeria
HOTH SEC FilingsHoth Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Hoth Therapeutics reports preclinical data on obesity treatment By Investing.com - Investing.com South Africa
Hoth Therapeutics Reports Positive Female Preclinical Data Showing HT-VA Restores Cholesterol Levels and Improves Lipid Metabolism in MASLD Model - PR Newswire
Hoth Therapeutics Inc Azioni (HOTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):